Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Practice Point
  • Published:

Antibiotics and flare of inflammatory bowel disease: threat or therapy?

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

References

  1. D'Haens GR et al. (1998) Early lesions of recurrent Crohn's disease caused by infusion of intestinal contents in excluded ileum. Gastroenterology 114: 262–267

    Article  CAS  Google Scholar 

  2. Demling L (1994) Is Crohn's disease caused by antibiotics? Hepatogastroenterology 41: 549–551

    CAS  PubMed  Google Scholar 

  3. Card T et al. (2004) Antibiotic use and the development of Crohn's disease. Gut 53: 246–250

    Article  CAS  Google Scholar 

  4. Rutgeerts P et al. (2005) Ornidazole for prophylaxis of postoperative Crohn's disease recurrence: a randomized, double-blind, placebo-controlled trial. Gastroenterology 128: 856–861

    Article  CAS  Google Scholar 

Download references

Acknowledgements

The synopsis was written by Rachel Jones, Associate Editor, Nature Clinical Practice.

Author information

Authors and Affiliations

Authors

Ethics declarations

Competing interests

The author declares no competing financial interests.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Logan, R. Antibiotics and flare of inflammatory bowel disease: threat or therapy?. Nat Rev Gastroenterol Hepatol 2, 446–447 (2005). https://doi.org/10.1038/ncpgasthep0286

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1038/ncpgasthep0286

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing